Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Paino
Reply to "Response to "CD20 Positive Cells Are Undetectable in the Majority of Multiple Myeloma Cell Lines and Are Not Associated With a Cancer Stem Cell Phenotype". Haematologica 2012;97(7):1110-1114
Haematologica
Hematology
Related publications
High Levels of Circulating CD34+ Cells at Autologous Stem Cell Collection Are Associated With Favourable Prognosis in Multiple Myeloma
British Journal of Cancer
Cancer Research
Oncology
Response to Dexamethasone Is Glucose-Sensitive in Multiple Myeloma Cell Lines
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Rituximab in CD20 Positive Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
CD133+ Glioblastoma Stem-Like Cells Are Radiosensitive With a Defective DNA Damage Response Compared With Established Cell Lines
Clinical Cancer Research
Cancer Research
Oncology
Four Proteins Governing Overangiogenic Endothelial Cell Phenotype in Patients With Multiple Myeloma Are Plausible Therapeutic Targets
Oncogene
Cancer Research
Genetics
Molecular Biology
Bruceantin Inhibits Multiple Myeloma Cancer Stem Cell Proliferation
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Impact of Tandem Autologous Stem Cell Transplantation and Response to Transplant in the Outcome of Multiple Myeloma
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.
Molecular Cancer Therapeutics
Cancer Research
Oncology
WARNING: G‐401 and SK‐NEP‐1 Cell Lines Are Not Wilms Tumor Cell Lines
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
